Nascent Biotech Inc (NBIO)
0.0996
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
Nascent Biotech 1 Year Total Returns (Daily): 99.20% for May 22, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 22, 2024 | 99.20% |
| May 21, 2024 | 54.84% |
| May 20, 2024 | 54.69% |
| May 17, 2024 | 38.19% |
| May 16, 2024 | 38.67% |
| May 15, 2024 | 41.42% |
| May 14, 2024 | 79.12% |
| May 13, 2024 | 79.12% |
| May 10, 2024 | 96.46% |
| May 09, 2024 | 88.66% |
| May 08, 2024 | 98.00% |
| May 07, 2024 | 92.80% |
| May 06, 2024 | 95.69% |
| May 03, 2024 | 91.92% |
| May 02, 2024 | 67.73% |
| May 01, 2024 | 63.03% |
| April 30, 2024 | 65.67% |
| April 29, 2024 | 65.67% |
| April 26, 2024 | 67.34% |
| April 25, 2024 | 66.50% |
| April 24, 2024 | 50.77% |
| April 23, 2024 | 23.58% |
| April 22, 2024 | 30.22% |
| April 19, 2024 | 87.22% |
| April 18, 2024 | 67.91% |
| Date | Value |
|---|---|
| April 17, 2024 | 65.80% |
| April 16, 2024 | 61.86% |
| April 15, 2024 | 102.9% |
| April 12, 2024 | 59.20% |
| April 11, 2024 | 30.88% |
| April 10, 2024 | 20.00% |
| April 09, 2024 | 75.32% |
| April 08, 2024 | 67.32% |
| April 05, 2024 | 128.6% |
| April 04, 2024 | 188.1% |
| April 03, 2024 | 188.1% |
| April 02, 2024 | 220.0% |
| April 01, 2024 | 228.0% |
| March 28, 2024 | 254.8% |
| March 27, 2024 | 231.5% |
| March 26, 2024 | 216.7% |
| March 25, 2024 | 180.3% |
| March 22, 2024 | 201.7% |
| March 21, 2024 | 188.7% |
| March 20, 2024 | 102.8% |
| March 19, 2024 | 101.4% |
| March 18, 2024 | 98.55% |
| March 15, 2024 | 77.00% |
| March 14, 2024 | 35.68% |
| March 13, 2024 | 23.18% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-86.25%
Minimum
Aug 11 2023
456.0%
Maximum
Sep 23 2022
17.14%
Average
-19.01%
Median
Jun 04 2019
1 Year Total Returns (Daily) Benchmarks
| NovaBay Pharmaceuticals Inc | -80.31% |
| Palatin Technologies Inc | -17.41% |
| iBio Inc | -87.87% |
| Theriva Biologics Inc | -46.76% |
| Oragenics Inc | -19.81% |